Expected earnings - XTL Biopharmaceuticals Ltd.
Source: US Earnings Reports
XTL Biopharmaceuticals Ltd. (XTLB) is expected to report for quarter end 2025-03-31
XTL Biopharmaceuticals Ltd.
NASDAQ: XTLB
XTLB Trading
-0.84% G/L:
$0.629 Last:
12,725 Volume:
$0.6523 Open:
XTLB Latest News
February 27, 2026 04:30:00 pm
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
January 23, 2026 04:10:00 pm
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
January 13, 2026 09:38:22 am
Morning Market Brief: From IP Land Grabs to FDA Greenlights, Small-Cap Innovation Takes Center Stage
XTLB Stock Data
$2,098,137
1,046,204
N/A
8
N/A
Biotechnology & Life Sciences
Healthcare
IL
Ramat Gan
